Literature DB >> 24436353

Dissociation of hepatic insulin resistance from susceptibility of nonalcoholic fatty liver disease induced by a high-fat and high-carbohydrate diet in mice.

Akihiro Asai1, Pauline M Chou, Heng-Fu Bu, Xiao Wang, M Sambasiva Rao, Anthony Jiang, Christine J DiDonato, Xiao-Di Tan.   

Abstract

Liver steatosis in nonalcoholic fatty liver disease is affected by genetics and diet. It is associated with insulin resistance (IR) in hepatic and peripheral tissues. Here, we aimed to characterize the severity of diet-induced steatosis, obesity, and IR in two phylogenetically distant mouse strains, C57BL/6J and DBA/2J. To this end, mice (male, 8 wk old) were fed a high-fat and high-carbohydrate (HFHC) or control diet for 16 wk followed by the application of a combination of classic physiological, biochemical, and pathological studies to determine obesity and hepatic steatosis. Peripheral IR was characterized by measuring blood glucose level, serum insulin level, homeostasis model assessment of IR, glucose intolerance, insulin intolerance, and AKT phosphorylation in adipose tissues, whereas the level of hepatic IR was determined by measuring insulin-triggered hepatic AKT phosphorylation. We discovered that both C57BL/6J and DBA/2J mice developed obesity to a similar degree without the feature of liver inflammation after being fed an HFHC diet for 16 wk. C57BL/6J mice in the HFHC diet group exhibited severe pan-lobular steatosis, a marked increase in hepatic triglyceride levels, and profound peripheral IR. In contrast, DBA/2J mice in the HFHC diet group developed only a mild degree of pericentrilobular hepatic steatosis that was associated with moderate changes in peripheral IR. Interestingly, both C57BL/6J and DBA/2J developed severe hepatic IR after HFHC diet treatment. Collectively, these data suggest that the severity of diet-induced hepatic steatosis is correlated to the level of peripheral IR, not with the severity of obesity and hepatic IR. Peripheral rather than hepatic IR is a dominant factor of pathophysiology in nonalcoholic fatty liver disease.

Entities:  

Keywords:  hepatic insulin resistance; insulin resistance; mice; nonalcoholic fatty liver disease; steatosis

Mesh:

Substances:

Year:  2014        PMID: 24436353      PMCID: PMC3949024          DOI: 10.1152/ajpgi.00291.2013

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  30 in total

1.  Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association.

Authors:  Gianfranco Pagano; Giovanni Pacini; Giovanni Musso; Roberto Gambino; Fabio Mecca; Nadia Depetris; Maurizio Cassader; Ezio David; Paolo Cavallo-Perin; Mario Rizzetto
Journal:  Hepatology       Date:  2002-02       Impact factor: 17.425

Review 2.  Animal models of steatosis.

Authors:  A Koteish; A M Diehl
Journal:  Semin Liver Dis       Date:  2001       Impact factor: 6.115

3.  Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities.

Authors:  A J Sanyal; C Campbell-Sargent; F Mirshahi; W B Rizzo; M J Contos; R K Sterling; V A Luketic; M L Shiffman; J N Clore
Journal:  Gastroenterology       Date:  2001-04       Impact factor: 22.682

4.  Impaired glucose homeostasis in insulin-like growth factor-binding protein-3-transgenic mice.

Authors:  Josef V Silha; Yaoting Gui; Liam J Murphy
Journal:  Am J Physiol Endocrinol Metab       Date:  2002-11       Impact factor: 4.310

5.  Comparison of insulin secretory function in two mouse models with different susceptibility to beta-cell failure.

Authors:  Suwattanee Kooptiwut; Sakeneh Zraika; Anne W Thorburn; Marjorie E Dunlop; Rima Darwiche; Thomas W Kay; Joseph Proietto; Sofianos Andrikopoulos
Journal:  Endocrinology       Date:  2002-06       Impact factor: 4.736

6.  Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.

Authors:  D R Matthews; J P Hosker; A S Rudenski; B A Naylor; D F Treacher; R C Turner
Journal:  Diabetologia       Date:  1985-07       Impact factor: 10.122

7.  Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms.

Authors:  E Bugianesi; A Gastaldelli; E Vanni; R Gambino; M Cassader; S Baldi; V Ponti; G Pagano; E Ferrannini; M Rizzetto
Journal:  Diabetologia       Date:  2005-03-04       Impact factor: 10.122

8.  Metabolic adaptations of three inbred strains of mice (C57BL/6, DBA/2, and 129T2) in response to a high-fat diet.

Authors:  Alexandra Funkat; Christine M Massa; Valentina Jovanovska; Joseph Proietto; Sofianos Andrikopoulos
Journal:  J Nutr       Date:  2004-12       Impact factor: 4.798

9.  Dietary-induced obesity and hypothalamic infertility in female DBA/2J mice.

Authors:  Drew V Tortoriello; Julie McMinn; Streamson C Chua
Journal:  Endocrinology       Date:  2003-12-11       Impact factor: 4.736

10.  Reversal of diet-induced obesity and diabetes in C57BL/6J mice.

Authors:  P I Parekh; A E Petro; J M Tiller; M N Feinglos; R S Surwit
Journal:  Metabolism       Date:  1998-09       Impact factor: 8.694

View more
  13 in total

1.  Activation of Insulin-PI3K/Akt-p70S6K Pathway in Hepatic Stellate Cells Contributes to Fibrosis in Nonalcoholic Steatohepatitis.

Authors:  Cindy X Cai; Hema Buddha; Shobha Castelino-Prabhu; Zhiwei Zhang; Robert S Britton; Bruce R Bacon; Brent A Neuschwander-Tetri
Journal:  Dig Dis Sci       Date:  2017-02-13       Impact factor: 3.199

Review 2.  The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes.

Authors:  Rachel J Perry; Varman T Samuel; Kitt F Petersen; Gerald I Shulman
Journal:  Nature       Date:  2014-06-05       Impact factor: 49.962

3.  Mouse models of diet-induced nonalcoholic steatohepatitis reproduce the heterogeneity of the human disease.

Authors:  Mariana Verdelho Machado; Gregory Alexander Michelotti; Guanhua Xie; Thiago Almeida Pereira; Thiago Pereira de Almeida; Jerome Boursier; Brittany Bohnic; Cynthia D Guy; Anna Mae Diehl
Journal:  PLoS One       Date:  2015-05-27       Impact factor: 3.240

4.  Effects of Choline on DNA Methylation and Macronutrient Metabolic Gene Expression in In Vitro Models of Hyperglycemia.

Authors:  Xinyin Jiang; Esther Greenwald; Chauntelle Jack-Roberts
Journal:  Nutr Metab Insights       Date:  2016-04-07

5.  Vitamin D3 supplementation of a high fat high sugar diet ameliorates prediabetic phenotype in female LDLR-/- and LDLR+/+ mice.

Authors:  Ramiar Kheder; James Hobkirk; Zeayd Saeed; Justyna Janus; Sean Carroll; Michael J Browning; Cordula Stover
Journal:  Immun Inflamm Dis       Date:  2017-03-13

6.  Trans-Fatty Acids Aggravate Obesity, Insulin Resistance and Hepatic Steatosis in C57BL/6 Mice, Possibly by Suppressing the IRS1 Dependent Pathway.

Authors:  Xiaona Zhao; Cheng Shen; Hong Zhu; Cong Wang; Xiangwei Liu; Xiaolei Sun; Shasha Han; Peng Wang; Zhen Dong; Xin Ma; Kai Hu; Aijun Sun; Junbo Ge
Journal:  Molecules       Date:  2016-05-30       Impact factor: 4.411

7.  Phoenixin 14 Inhibits High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in Experimental Mice.

Authors:  Fan Yang; Ping Huang; Liandong Shi; Feng Liu; Aimei Tang; Shaohui Xu
Journal:  Drug Des Devel Ther       Date:  2020-09-22       Impact factor: 4.162

8.  Berberine Ameliorates Hepatic Insulin Resistance by Regulating microRNA-146b/SIRT1 Pathway.

Authors:  Miao Sui; Xiaofei Jiang; Hongping Sun; Chao Liu; Yaofu Fan
Journal:  Diabetes Metab Syndr Obes       Date:  2021-06-04       Impact factor: 3.168

9.  Capsaicin suppresses liver fat accumulation in high-fat diet-induced NAFLD mice.

Authors:  Mi Kyung Shin; Soo-Man Yang; In-Seob Han
Journal:  Anim Cells Syst (Seoul)       Date:  2020-08-26       Impact factor: 1.815

10.  Prenatal Choline Supplementation during High-Fat Feeding Improves Long-Term Blood Glucose Control in Male Mouse Offspring.

Authors:  Hunter W Korsmo; Kaydine Edwards; Bhoomi Dave; Chauntelle Jack-Roberts; Huanling Yu; Anjana Saxena; Marie Salvador; Moshe Dembitzer; Jaskomal Phagoora; Xinyin Jiang
Journal:  Nutrients       Date:  2020-01-04       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.